Cargando…
P38 Mediates Tumor Suppression through Reduced Autophagy and Actin Cytoskeleton Changes in NRAS-Mutant Melanoma
SIMPLE SUMMARY: Mutations in NRAS are the second most common driver mutation in melanoma and lack therapy options. We discovered that p38 plays the role of a tumor suppressor in NRAS mutant melanoma. In this study, we characterized the significance of short and long term p38 activation which can in...
Autores principales: | Banik, Ishani, Ghosh, Adhideb, Beebe, Erin, Burja, Blaž, Bertoncelj, Mojca Frank, Dooley, Christopher M., Markkanen, Enni, Dummer, Reinhard, Busch-Nentwich, Elisabeth M., Levesque, Mitchell P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913513/ https://www.ncbi.nlm.nih.gov/pubmed/36765834 http://dx.doi.org/10.3390/cancers15030877 |
Ejemplares similares
Ejemplares similares
-
Hi-JAKi-ng Synovial Fibroblasts in Inflammatory Arthritis With JAK Inhibitors
por: Burja, Blaž, et al.
Publicado: (2020) -
Targeted treatment of advanced NRAS-mutated melanoma
por: Koelblinger, Peter, et al.
Publicado: (2017) -
Long‐Term Response to Intermittent Binimetinib in Patients with NRAS‐Mutant Melanoma
por: Matter, Alexandra Valeska, et al.
Publicado: (2020) -
Fission Yeast Sec3 Bridges the Exocyst Complex to the Actin Cytoskeleton
por: Jourdain, Isabelle, et al.
Publicado: (2012) -
p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during development and aging
por: Tormos, Ana M., et al.
Publicado: (2017)